Mechanisms of inhibitory effects of CD-349 and K+-channel activators on noradrenaline-induced contraction and changes in levels of cyclic GMP in rat aorta

This publication has 14 references indexed in Scilit:

• Functional changes in potassium channels in aortas from rats with streptozotocin-induced diabetes
  European Journal of Pharmacology, 1989
• Impairment of endothelium‐dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin‐induced diabetic rats
  British Journal of Pharmacology, 1989
• Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein
  Biochemical Pharmacology, 1989
• Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery
  European Journal of Pharmacology, 1989
• A New Ca-Antagonist, CD-349, Binding to the Ca-Channel of Rat Myocardium and Brain and Hog Coronary Artery
  The Japanese Journal of Pharmacology, 1988
• The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on ⁸⁶Rb efflux in rat blood vessels
  British Journal of Pharmacology, 1986
• Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta.
  Circulation Research, 1986
• Activation of phosphatidylinositol turnover in rat aorta by α1-adrenergic receptor stimulation
  European Journal of Pharmacology, 1985
• EFFECTS OF 2-NICOTINAMIDOETHYL NITRATE (NICORANDIL - SG-75) AND ITS DERIVATIVES ON SMOOTH-MUSCLE CELLS OF THE CANINE MESENTERIC-ARTERY
  1984
• Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG-75)
  Journal of Cardiovascular Pharmacology, 1983